vs
Side-by-side financial comparison of AGENUS INC (AGEN) and FGI Industries Ltd. (FGI). Click either name above to swap in a different company.
AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $30.5M, roughly 1.1× FGI Industries Ltd.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -31.0%, a 22.4% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs -14.4%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs -0.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
AGEN vs FGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $30.5M |
| Net Profit | $-10.6M | $-2.6M |
| Gross Margin | — | 26.7% |
| Operating Margin | 42.1% | -2.2% |
| Net Margin | -31.0% | -8.6% |
| Revenue YoY | 27.5% | -14.4% |
| Net Profit YoY | 77.3% | -553.1% |
| EPS (diluted) | $0.09 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $30.5M | ||
| Q3 25 | $30.2M | $35.8M | ||
| Q2 25 | $25.7M | $31.0M | ||
| Q1 25 | $24.1M | $33.2M | ||
| Q4 24 | $26.8M | $35.6M | ||
| Q3 24 | $25.1M | $36.1M | ||
| Q2 24 | $23.5M | $29.4M | ||
| Q1 24 | $28.0M | $30.8M |
| Q4 25 | $-10.6M | $-2.6M | ||
| Q3 25 | $63.9M | $-1.7M | ||
| Q2 25 | $-30.0M | $-1.2M | ||
| Q1 25 | $-26.4M | $-629.1K | ||
| Q4 24 | $-46.8M | $-402.3K | ||
| Q3 24 | $-67.2M | $-550.1K | ||
| Q2 24 | $-54.8M | $163.6K | ||
| Q1 24 | $-63.5M | $-412.2K |
| Q4 25 | — | 26.7% | ||
| Q3 25 | 97.9% | 26.5% | ||
| Q2 25 | 99.1% | 28.1% | ||
| Q1 25 | 99.4% | 26.8% | ||
| Q4 24 | 99.6% | 24.6% | ||
| Q3 24 | 99.4% | 25.8% | ||
| Q2 24 | 99.5% | 30.5% | ||
| Q1 24 | 99.6% | 27.4% |
| Q4 25 | 42.1% | -2.2% | ||
| Q3 25 | -15.0% | 1.0% | ||
| Q2 25 | -65.0% | -2.7% | ||
| Q1 25 | -55.3% | -3.9% | ||
| Q4 24 | -96.5% | -3.5% | ||
| Q3 24 | -125.5% | -0.2% | ||
| Q2 24 | -128.4% | -1.5% | ||
| Q1 24 | -117.4% | -1.0% |
| Q4 25 | -31.0% | -8.6% | ||
| Q3 25 | 211.4% | -4.6% | ||
| Q2 25 | -116.8% | -4.0% | ||
| Q1 25 | -109.6% | -1.9% | ||
| Q4 24 | -174.4% | -1.1% | ||
| Q3 24 | -267.7% | -1.5% | ||
| Q2 24 | -233.1% | 0.6% | ||
| Q1 24 | -226.6% | -1.3% |
| Q4 25 | $0.09 | $-1.63 | ||
| Q3 25 | $1.94 | $-0.86 | ||
| Q2 25 | $-1.00 | $-0.64 | ||
| Q1 25 | $-1.03 | $-0.07 | ||
| Q4 24 | $-1.95 | $-0.38 | ||
| Q3 24 | $-3.08 | $-0.29 | ||
| Q2 24 | $-2.52 | $0.08 | ||
| Q1 24 | $-3.04 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $1.9M |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $17.3M |
| Total Assets | $226.8M | $69.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $1.9M | ||
| Q3 25 | $3.5M | $1.9M | ||
| Q2 25 | $9.5M | $2.5M | ||
| Q1 25 | $18.5M | $1.2M | ||
| Q4 24 | $40.4M | $4.6M | ||
| Q3 24 | $44.8M | $3.0M | ||
| Q2 24 | $93.7M | $1.3M | ||
| Q1 24 | $52.9M | $3.3M |
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $17.3M | ||
| Q3 25 | $-274.1M | $19.7M | ||
| Q2 25 | $-354.6M | $21.3M | ||
| Q1 25 | $-341.8M | $21.8M | ||
| Q4 24 | $-326.4M | $22.3M | ||
| Q3 24 | $-292.3M | $23.5M | ||
| Q2 24 | $-241.3M | $23.8M | ||
| Q1 24 | $-201.4M | $23.9M |
| Q4 25 | $226.8M | $69.5M | ||
| Q3 25 | $233.9M | $73.0M | ||
| Q2 25 | $185.2M | $71.7M | ||
| Q1 25 | $200.2M | $68.5M | ||
| Q4 24 | $226.3M | $75.5M | ||
| Q3 24 | $238.5M | $74.7M | ||
| Q2 24 | $292.4M | $69.9M | ||
| Q1 24 | $256.6M | $68.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.3M |
| FCF MarginFCF / Revenue | — | 7.5% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-212.5K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $2.3M | ||
| Q3 25 | $-14.7M | $-1.9M | ||
| Q2 25 | $-20.2M | $7.6M | ||
| Q1 25 | $-25.6M | $-7.4M | ||
| Q4 24 | $-28.7M | $617.4K | ||
| Q3 24 | $-53.3M | $-915.0K | ||
| Q2 24 | $-38.2M | $862.1K | ||
| Q1 24 | $-38.2M | $-8.0M |
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | $-20.2M | $7.4M | ||
| Q1 25 | $-25.6M | $-7.7M | ||
| Q4 24 | $-28.7M | $-214.1K | ||
| Q3 24 | $-53.3M | $-1.1M | ||
| Q2 24 | $-38.6M | $281.5K | ||
| Q1 24 | $-38.2M | $-8.6M |
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | -5.9% | ||
| Q2 25 | -78.7% | 23.8% | ||
| Q1 25 | -106.5% | -23.3% | ||
| Q4 24 | -107.0% | -0.6% | ||
| Q3 24 | -212.2% | -3.0% | ||
| Q2 24 | -164.4% | 1.0% | ||
| Q1 24 | -136.5% | -28.0% |
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 1.1% | ||
| Q4 24 | 0.3% | 2.3% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 2.0% | 2.0% | ||
| Q1 24 | 0.1% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | -0.23× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
